{
  "schemaVersion" : 2,
  "registerId" : "F2017L00020",
  "instrumentNumber" : "11/2017",
  "citation" : "Statement of Principles concerning hepatitis D (Reasonable Hypothesis) (No. 11 of 2017)",
  "conditionName" : "hepatitis D",
  "effectiveFrom" : "2017-01-23",
  "standardOfProof" : "Reasonable Hypothesis",
  "icdCodes" : [ {
    "version" : "ICD-10-AM",
    "code" : "B16.0"
  }, {
    "version" : "ICD-10-AM",
    "code" : "B16.1"
  }, {
    "version" : "ICD-10-AM",
    "code" : "B17.0"
  }, {
    "version" : "ICD-10-AM",
    "code" : "B18.0"
  } ],
  "onsetFactors" : [ {
    "paragraph" : "9(1)",
    "text" : "being exposed to the hepatitis D virus at least 14 days before the\r\nclinical onset of hepatitis D",
    "definedTerms" : [ {
      "term" : "being exposed to the hepatitis D virus",
      "definition" : "means having percutaneous\r\n(intravenous, intramuscular, subcutaneous or intradermal) or permucosal\r\nexposure to a body substance as specified which is derived from a person\r\ninfected with the hepatitis D virus.\r\nNote: body substance as specified is also defined in the Schedule 1 - Dictionary."
    } ]
  } ],
  "aggravationFactors" : [ {
    "paragraph" : "9(2)",
    "text" : "inability to obtain appropriate clinical management for hepatitis D",
    "definedTerms" : [ ]
  } ]
}